Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.700.640.790.981.08

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.70 based on Mar2025 Standalone results.
Year Fixed Capital/Sales
Mar20250.70
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.7
9.37
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹647.5 Cr -4% 26.5% 229% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,000.0 Cr -1.5% -1.6% 35.6% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4%

26.5%

229%

SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses